Atlas Trials

Clarithromycin in Multiple Myeloma Induction Therapy

Clinical trial NCT02573935 · TERMINATED

Trial details

NCT number
NCT02573935
Sponsor
Henrik Gregersen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-01-01
Primary completion
2016-09-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.